Financial News
Latest News about SAVA
Recent news which mentions SAVA
Rebuilding Connections, Fostering Growth: Synaptogenix Could Be A Beacon of Hope for Patients With Neurological Diseases
October 05, 2021
From Benzinga
How David Green Traded Moderna For A Big Profit On Monday Morning
October 04, 2021
From Benzinga
Tickers
SAVA
From InvestorPlace
What to Make of Cassava Sciences’ Late September Rally
October 04, 2021
Tickers
SAVA
From InvestorPlace
Cassava Stock Has Reached a Positive Turning Point
October 01, 2021
From InvestorPlace
Is Cassava Sciences Back in the Game?
September 28, 2021
From Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
September 24, 2021
From Benzinga
58 Biggest Movers From Yesterday
September 24, 2021
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
September 23, 2021
From Benzinga
MRM Stock: The Hair Salon Deal That has Holistic Healthcare Play Medirom All Lathered Up Today
September 23, 2021
From InvestorPlace
SAVA Stock: What Is Going on With Red-Hot Cassava Sciences Today?
September 22, 2021
Tickers
SAVA
From InvestorPlace
Cassava Sciences Can Recover Despite Harsh Allegations
September 21, 2021
Tickers
SAVA
From InvestorPlace
It’s Best to Stick to the Fundamentals With Skillz Stock
September 20, 2021
From InvestorPlace
Cassava Sciences Has Value and Is Likely To Proceed to Phase 3
September 17, 2021
Tickers
SAVA
From InvestorPlace
46 Biggest Movers From Yesterday
September 15, 2021
From Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
September 14, 2021
From Benzinga
36 Stocks Moving In Tuesday's Mid-Day Session
September 14, 2021
From Benzinga
The 5 DeFi Tokens That Could Change Finance As We Know It
September 13, 2021
From InvestorPlace
Cassava Stock Is a Bold Play That Could Pay Off Soon
September 13, 2021
From InvestorPlace
What Happens When A Biotech Stock Blows Up: How Our Hedged Portfolio Method Limited The Damage With Cassava Sciences
September 11, 2021
From Benzinga
Cassava Sciences Stock Still Poses Risks After Absorbing Data Controversy
September 09, 2021
From InvestorPlace
7 Busted Biotech Stocks Due for a Rebound
September 08, 2021
From InvestorPlace
Better Buy: Biogen vs. Cassava Sciences
September 04, 2021
From Motley Fool
Cassava Sciences CEO says ‘enormous profit motive’ behind N.Y. law firm’s fraud allegations
September 03, 2021
From MarketWatch
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
